Pulmonary Embolism News and Research

RSS

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.

Investigating plasma signatures of platelet-derived proteins in acute pulmonary embolism

In a new study, researchers determined plasma signatures of proteins related to or derived from platelets in acute isolated pulmonary embolism (iPE) and deep vein thrombosis-associated PE (DVT-PE), compared to isolated DVT (iDVT).

17 Oct 2022

Marijuana-dependent patients may face higher infection rates following knee and shoulder arthroscopy

Patients who are dependent on marijuana may face higher infection rates following knee and shoulder arthroscopy - a minimally invasive surgery in which a small camera is inserted to diagnose and sometimes treat injury - according to a study presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

17 Oct 2022

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

14 Oct 2022

$Over-the-counter aspirin effective in preventing blood clots following surgery to repair bone fractures$

Over-the-counter aspirin effective in preventing blood clots following surgery to repair bone fractures

Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial found that over-the-counter aspirin is just as effective.

14 Oct 2022

Population-wide cohort study detects increase in major arterial and venous thrombotic events immediately after COVID-19 diagnoses

In a new study, researchers explored the association between coronavirus disease 2019 (COVID-19) and vascular thrombotic events using a population-wide cohort study across England and Wales.

21 Sep 2022

Study: Life-threatening blood clots remain for at least 49 weeks after COVID-19

COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.

21 Sep 2022

New catheter leads to a remarkable reduction in pulmonary artery obstruction

A device known as the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, researchers from the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation session at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference in Boston.

19 Sep 2022

Combined oral contraceptives associated with elevated risk of venous thromboembolism in obese women

Obese women who use oral contraceptives containing estrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to a review paper published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).

14 Sep 2022

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related complications after surgery, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.

12 Sep 2022

Study suggests strategies to bolster the administration of clot-busting drugs

Venous thromboembolism (VTE) is a potentially deadly condition in which a blood clot (known as a deep vein thrombosis [DVT]) forms in the deep veins of the leg, groin or arm and may dislodge.

1 Sep 2022

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

A heart check-up is recommended in even apparently healthy people over 65 years of age before intermediate- or high-risk non-cardiac surgery, according to European Society of Cardiology (ESC) Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery published online today in European Heart Journal.

26 Aug 2022

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines for the diagnosis and treatment of pulmonary hypertension, published online today in European Heart Journal and the European Respiratory Journal.

26 Aug 2022

What is the association between COVID-19 and thrombotic events?

In a new study, researchers assessed the association of COVID-19 and influenza with thrombotic events among patients.

18 Aug 2022

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.

9 Aug 2022

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Researchers describe failures of the French healthcare system as reflected by increased hospitalizations due to certain acute cardiovascular diseases in 2021.

7 Aug 2022

Researchers delve deeper into the structure of protein receptor crucial for cardiovascular health

5 Aug 2022

Higher suPAR levels linked with increased risk of blood clot formation

Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms - blood clots that travel to the lungs. In fact, in nearly one third of patients with COVID-19, these clots led to death.

4 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Researchers determined whether the incidence of new diabetes mellitus (DM) and cardiovascular diseases (CVDs) increases in a year among those recovering from COVID-19.

21 Jul 2022

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes, particularly in the three months following infection, according to a new study by Emma Rezel-Potts, Martin Gulliford, and colleagues of King's College London, United Kingdom, publishing July 19th in the open access journal PLOS Medicine.

20 Jul 2022